Status:
RECRUITING
The EXPLORE MG Registry for Myasthenia Gravis
Lead Sponsor:
Yale University
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myast...
Detailed Description
This registry will allow for the research of several mechanisms of Myasthenia Gravis (MG) by studying peripheral blood, stool, disease status and course, and treatment of subjects with MG. The EXPLORE...
Eligibility Criteria
Inclusion
- Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.
Exclusion
- Failure to meet the Inclusion Criteria.
Key Trial Info
Start Date :
March 30 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03792659
Start Date
March 30 2016
End Date
October 30 2026
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Hospital
New Haven, Connecticut, United States, 06510